Search research articles
Contact Us
Filters
Showing results (251-260 of 392) with videos related to
Page
of 40
Sort By:
Molecular Metabolism
|
April 9, 2023
The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326
Brian E Ford, Shruti S Chachra, Katrina Rodgers, et al.
JHEP Reports : Innovation in Hepatology
|
October 9, 2024
Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study
Joost Boeckmans, Maurice Michel, Alexander Gieswinkel, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 27, 2014
[Etiology and complications of liver cirrhosis: data from a German centre]
V Sivanathan, J M Kittner, M F Sprinzl, et al.
Transplantation Proceedings
|
September 1, 2009
Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation
T Zimmermann, C Otto, M Hoppe-Lotichius, et al.
JHEP Reports : Innovation in Hepatology
|
April 18, 2022
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
Aidan J McGlinchey, Olivier Govaere, Dawei Geng, et al.
International Journal of Oncology
|
February 27, 2013
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma
Anja Lautem, Michael Heise, Andreas Gräsel, et al.
Ophthalmology
|
February 19, 2025
Incidence of Retinal Vein Occlusion and Its Association with Mortality: Results from the Gutenberg Health Study
Anna Maria Voigt, Hisham Elbaz, Elsa Wilma Böhm, et al.
Iscience
|
September 6, 2022
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease
Partho Sen, Olivier Govaere, Tim Sinioja, et al.
Scientific Reports
|
March 7, 2024
Noise annoyance and cardiovascular disease risk: results from a 10-year follow-up study
Omar Hahad, Donya Gilan, Matthias Michal, et al.
Arthritis Research & Therapy
|
April 23, 2011
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis
Kristine L Stump, Lily D Lu, Pawel Dobrzanski, et al.
Page
of 40
Search research articles
Search
Showing results (251-260 of 392) with videos related to
Sort By:
Page
of 40
Molecular Metabolism
|
April 9, 2023
The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326
Brian E Ford, Shruti S Chachra, Katrina Rodgers, et al.
JHEP Reports : Innovation in Hepatology
|
October 9, 2024
Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study
Joost Boeckmans, Maurice Michel, Alexander Gieswinkel, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 27, 2014
[Etiology and complications of liver cirrhosis: data from a German centre]
V Sivanathan, J M Kittner, M F Sprinzl, et al.
Transplantation Proceedings
|
September 1, 2009
Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation
T Zimmermann, C Otto, M Hoppe-Lotichius, et al.
JHEP Reports : Innovation in Hepatology
|
April 18, 2022
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
Aidan J McGlinchey, Olivier Govaere, Dawei Geng, et al.
International Journal of Oncology
|
February 27, 2013
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma
Anja Lautem, Michael Heise, Andreas Gräsel, et al.
Ophthalmology
|
February 19, 2025
Incidence of Retinal Vein Occlusion and Its Association with Mortality: Results from the Gutenberg Health Study
Anna Maria Voigt, Hisham Elbaz, Elsa Wilma Böhm, et al.
Iscience
|
September 6, 2022
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease
Partho Sen, Olivier Govaere, Tim Sinioja, et al.
Scientific Reports
|
March 7, 2024
Noise annoyance and cardiovascular disease risk: results from a 10-year follow-up study
Omar Hahad, Donya Gilan, Matthias Michal, et al.
Arthritis Research & Therapy
|
April 23, 2011
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis
Kristine L Stump, Lily D Lu, Pawel Dobrzanski, et al.
Page
of 40